BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28350553)

  • 1. Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.
    Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):328-337. PubMed ID: 28350553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant.
    Salgado M; Kwon M; Gálvez C; Badiola J; Nijhuis M; Bandera A; Balsalobre P; Miralles P; Buño I; Martinez-Laperche C; Vilaplana C; Jurado M; Clotet B; Wensing A; Martinez-Picado J; Diez-Martin JL;
    Ann Intern Med; 2018 Nov; 169(10):674-683. PubMed ID: 30326031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.
    Henrich TJ; Hanhauser E; Marty FM; Sirignano MN; Keating S; Lee TH; Robles YP; Davis BT; Li JZ; Heisey A; Hill AL; Busch MP; Armand P; Soiffer RJ; Altfeld M; Kuritzkes DR
    Ann Intern Med; 2014 Sep; 161(5):319-27. PubMed ID: 25047577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
    Gupta RK; Abdul-Jawad S; McCoy LE; Mok HP; Peppa D; Salgado M; Martinez-Picado J; Nijhuis M; Wensing AMJ; Lee H; Grant P; Nastouli E; Lambert J; Pace M; Salasc F; Monit C; Innes AJ; Muir L; Waters L; Frater J; Lever AML; Edwards SG; Gabriel IH; Olavarria E
    Nature; 2019 Apr; 568(7751):244-248. PubMed ID: 30836379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
    Salgado M; Gálvez C; Nijhuis M; Kwon M; Cardozo-Ojeda EF; Badiola J; Gorman MJ; Huyveneers LEP; Urrea V; Bandera A; Jensen BO; Vandekerckhove L; Jurado M; Raj K; Schulze Zur Wiesch J; Bailén R; Eberhard JM; Nabergoj M; Hütter G; Saldaña-Moreno R; Oldford S; Barrett L; Ramirez MLM; Garba S; Gupta RK; Revollo B; Ferra-Coll C; Kuball J; Alter G; Sáez-Cirión A; Diez-Martin JL; Duke ER; Schiffer JT; Wensing A; Martinez-Picado J;
    Lancet HIV; 2024 Jun; 11(6):e389-e405. PubMed ID: 38816141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.
    Sorà F; Antinori A; Piccirillo N; De Luca A; Chiusolo P; Cingolani A; Laurenti L; Rutella S; Ortona L; Leone G; Sica S
    Exp Hematol; 2002 Mar; 30(3):279-84. PubMed ID: 11882366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.
    Henrich TJ; Hu Z; Li JZ; Sciaranghella G; Busch MP; Keating SM; Gallien S; Lin NH; Giguel FF; Lavoie L; Ho VT; Armand P; Soiffer RJ; Sagar M; Lacasce AS; Kuritzkes DR
    J Infect Dis; 2013 Jun; 207(11):1694-702. PubMed ID: 23460751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.
    Fraser C; Ferguson NM; Ghani AC; Prins JM; Lange JM; Goudsmit J; Anderson RM; de Wolf F
    AIDS; 2000 Apr; 14(6):659-69. PubMed ID: 10807189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case report.
    Gupta RK; Peppa D; Hill AL; Gálvez C; Salgado M; Pace M; McCoy LE; Griffith SA; Thornhill J; Alrubayyi A; Huyveneers LEP; Nastouli E; Grant P; Edwards SG; Innes AJ; Frater J; Nijhuis M; Wensing AMJ; Martinez-Picado J; Olavarria E
    Lancet HIV; 2020 May; 7(5):e340-e347. PubMed ID: 32169158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
    Deeks SG; Wagner B; Anton PA; Mitsuyasu RT; Scadden DT; Huang C; Macken C; Richman DD; Christopherson C; June CH; Lazar R; Broad DF; Jalali S; Hege KM
    Mol Ther; 2002 Jun; 5(6):788-97. PubMed ID: 12027564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
    PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
    Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
    Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy.
    Henrich TJ; Hobbs KS; Hanhauser E; Scully E; Hogan LE; Robles YP; Leadabrand KS; Marty FM; Palmer CD; Jost S; Körner C; Li JZ; Gandhi RT; Hamdan A; Abramson J; LaCasce AS; Kuritzkes DR
    J Infect Dis; 2017 Jul; 216(2):254-262. PubMed ID: 28838149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.
    Peterson CW; Benne C; Polacino P; Kaur J; McAllister CE; Filali-Mouhim A; Obenza W; Pecor TA; Huang ML; Baldessari A; Murnane RD; Woolfrey AE; Jerome KR; Hu SL; Klatt NR; DeRosa S; Sékaly RP; Kiem HP
    JCI Insight; 2017 Feb; 2(4):e91230. PubMed ID: 28239658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning.
    Li Q; Rane L; Poiret T; Zou J; Magalhaes I; Ahmed R; Du Z; Vudattu N; Meng Q; Gustafsson-Jernberg Å; Winiarski J; Ringdén O; Maeurer M; Remberger M; Ernberg I
    Oncotarget; 2016 May; 7(21):30230-40. PubMed ID: 27102298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.